| Name | Title | Contact Details |
|---|
BioMedical Strategies is a La Jolla, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Mach7, our purpose is simple: to deliver to healthcare professionals the tools they need to help their patients achieve better health outcomes. Every day, medical practitioners face the challenge of bringing together an immense amount of patient data from multiple disparate sources while also finding a way to make sense of it. They must contend with issues like non-consolidated image storage, labor-intensive and inefficient workflows, and multiple viewers for different specialties and image types. With these obstacles in mind, Mach7 has built innovative solutions from the ground up that can integrate multiple systems, enable clinical collaboration, deliver vendor neutral archiving, provide enterprise-wide universal viewing, modernize legacy PACS, and more. Mach7 is focused on removing the technology limitations that inhibit the free flow of patient information and access to the complete patient medical record. We differ from many other companies in the industry by building an integrated imaging ecosystem where all technologies work together in harmony. Because we are built as an integration platform first, we give you the freedom to use the technologies that are important to your physicians and patients, even if they are from another vendor. This also means we offer the independence and flexibility to deploy these as individual components or a comprehensive end-to-end enterprise imaging platform. Through this, we help organizations increase their efficiency, achieve profound operational cost savings, leverage their existing IT investments, improve the experience for patients and medical professionals, and, ultimately, support healthier outcomes.
At CoorsTek Medical, our vision is to make lives measurably better. We are the partner of choice for medical innovators and medical-device providers worldwide whose success requires access to leading-edge medical device development experts and the related set of specialized product development and manufacturing capabilities.
Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. As The Imaging Phenomics Company®, Median provides insights into novel therapies and treatment strategies. Our unique solutions, MediScan® for lesion management in patient care, Lesion Management Solution (LMS) for lesion detection, measurement and reporting in clinical trials, and our imaging phenotyping system iBiopsy®, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world in bringing new and targeted treatments to patients in need with an eye on reducing overall costs. This is how we are helping to create a healthier world. Founded in 2002, based in Sophia-Antipolis, France, with a US subsidiary in Boston, Median has received the label “Innovative company” by the BPI and is listed on Euronext Paris` Alternext market (ISIN: FR0011049824, ticker: ALMDT). The company is eligible for the PEA-PME SME equity savings plan setup and has received the label Pass French Tech Promotion 2016-2017.
Penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. We design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. Today we have over 1,300 employees with sales operations in North America, Europe, Latin America, Australia and Asia. Members of the Penumbra team agree that this is where their work has meaning -- we are transforming the treatment of some of the world`s most devastating conditions. Penumbra is where everyone`s ideas matter, and where learning and growth are constant.